Skip to main content

Published locations for Novel antidepressant shines in phase 2 trial, but FDA has issues with its NDA

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Novel antidepressant shines in phase 2 trial, but FDA has issues with its NDA

User login

  • Reset your password
  • /content/novel-antidepressant-shines-phase-2-trial-fda-has-issues-its-nda
  • /familypracticenews/article/244220/depression/novel-antidepressant-shines-phase-2-trial-fda-has
  • /fedprac/article/244220/depression/novel-antidepressant-shines-phase-2-trial-fda-has-issues-its-nda
  • /internalmedicinenews/article/244220/depression/novel-antidepressant-shines-phase-2-trial-fda-has
  • /neurologyreviews/article/244220/depression/novel-antidepressant-shines-phase-2-trial-fda-has-issues
  • /jcomjournal/article/244220/depression/novel-antidepressant-shines-phase-2-trial-fda-has-issues-its
  • /psychiatry/article/244220/depression/novel-antidepressant-shines-phase-2-trial-fda-has-issues-its
  • /internalmedicine/article/244220/depression/novel-antidepressant-shines-phase-2-trial-fda-has-issues
  • /neurology/article/244220/depression/novel-antidepressant-shines-phase-2-trial-fda-has-issues-its-nda
  • /familymedicine/article/244220/depression/novel-antidepressant-shines-phase-2-trial-fda-has-issues
  • /clinicalpsychiatrynews/article/244220/depression/novel-antidepressant-shines-phase-2-trial-fda-has